Literature DB >> 3260156

Diminished response to an inhibitory signal in lymphocytes from patients with systemic lupus erythematosus.

M Salata1, J Golbus, B C Richardson.   

Abstract

Systemic lupus erythematosus is an autoimmune disease characterized by B-cell hyperactivity, resulting in polyclonal hypergammaglobulinaemia. One mechanism potentially resulting in excessive immunoglobulin synthesis is a diminished response to inhibitory signals. To test this hypothesis, anti-IgG antisera was used to inhibit pokeweed mitogen activation of cultured lymphocytes from lupus patients and controls. Inhibition of IgG secretion by B cells from lupus patients required more than 75 times as much anti-IgG as normal controls (P less than 0.005), indicating that lupus lymphocytes are hyporesponsive to this inhibitory signal. Similar studies with DR3+ controls demonstrated that diminished responsiveness to anti-IgG inhibition may in part be associated with the HLA-DR3 allele. Defects in this inhibitory mechanism may play a role in the B-cell hyperactivity observed in lupus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260156      PMCID: PMC1541662     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies.

Authors:  N E Phillips; D C Parker
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

2.  Immunopathogenesis of systemic lupus erythematosus.

Authors:  D Koffler; G Biesecker; S M Katz
Journal:  Arthritis Rheum       Date:  1982-07

Review 3.  The Fc-receptor: its role in the transmission of differentiation signals.

Authors:  E Kölsch; J Oberbarnscheidt; K Brüner; J Heuer
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

4.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

5.  Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.

Authors:  A S Fauci; H M Moutsopoulos
Journal:  Arthritis Rheum       Date:  1981-04

6.  Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.

Authors:  T J Lawley; R P Hall; A S Fauci; S I Katz; M I Hamburger; M M Frank
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

7.  The maintenance of B-cell and T-cell function in frozen and stored human lymphocytes.

Authors:  S L Donaldson; G A Miller; P L Rice; R R Ranney; J G Tew
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

8.  Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults.

Authors:  R P Kimberly; A Gibofsky; J E Salmon; M Fotino
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

9.  Defective B cell tolerance in adult (NZB X MZW)F1 mice.

Authors:  E A Goldings; P L Cohen; S F McFadden; M Ziff; E S Vitetta
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.

Authors:  G J Prud'Homme; C L Park; T M Fieser; R Kofler; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

View more
  2 in total

1.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events.

Authors:  S N Liossis; B Kovacs; G Dennis; G M Kammer; G C Tsokos
Journal:  J Clin Invest       Date:  1996-12-01       Impact factor: 14.808

2.  The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.

Authors:  Yun-Yan Zhu; Yin Su; Zhan-Guo Li; Yu Zhang
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.